SAB Biotherapeutics, Inc. (SABS)
4.00
+0.14
(+3.63%)
USD |
NASDAQ |
Jun 18, 16:00
3.995
0.00 (0.00%)
After-Hours: 20:00
SAB Biotherapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -585.0% |
| September 30, 2024 | |
| June 30, 2024 | -288.4% |
| March 31, 2024 | -110.1% |
| December 31, 2023 | -209.6% |
| September 30, 2023 | 22.24% |
| June 30, 2023 | -943.5% |
| March 31, 2023 | -58.87% |
| Date | Value |
|---|---|
| December 31, 2022 | 57.26% |
| September 30, 2022 | 74.65% |
| June 30, 2022 | 0.00% |
| March 31, 2022 | 0.00% |
| December 31, 2021 | 0.00% |
| September 30, 2021 | 97.20% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -22.95% |
| Return on Assets | -19.63% |
| Return on Invested Capital | -21.76% |
| Return on Net Operating Assets | -131.4% |